Now Available: Estonia Pharmaceuticals & Healthcare Report Q1 2014
Data for pharmaceutical sales in Q213 indicate that the market is experiencing a slowdown in growth, which is in line with our forecasts for the full year. However, growth in Q213 compared to Q212 declined significantly, indicating that the relatively small market is now mirroring the macroeconomic picture in Estonia. We expect Estonia's commitment to balanced budgets and fiscally conservative policies on government spending to moderate growth in the pharmaceutical market, with the slowdown in growth to continue into 2014....
View full press release